Two Columns, One Decision: Why Identity Testing Must Sit Beside the Purity Percentage

In a short, stability-conscious study window, the purity percentage is the number that gets quoted in the lab meeting — and the one that quietly gets trusted too far. A figure such as ≥99% is a useful release metric, but it is a measurement of proportion, not a statement of what the material actually is. Once a vial is opened, aliquoted and carried through a compressed experimental timeline, there is little scope to discover that the principal peak was not the intended compound. For that reason, identity testing has to be read alongside purity, not behind it. All materials discussed here are supplied strictly for controlled laboratory and analytical research; they are not for human or veterinary use.

What a Purity Percentage Can and Cannot Tell You

A purity figure is a relative measurement, not an absolute statement of vial contents. When a laboratory reports ≥99% purity by HPLC, that number generally describes the proportion of the detected chromatographic signal assigned to the principal peak under the conditions used. It answers a narrow question — how much of what was detected is the main species — and it does so only within the chosen detection window and wavelength. It does not, by itself, confirm that the main peak corresponds to the molecule named on the label.

The distinction matters because purity is inherently comparative. A closely related analogue, an oxidised variant, a truncated sequence or an isomer may elute near the target and be integrated either into the main peak or as a small shoulder, depending on the method applied. Two batches could both report ≥99% and still differ in what that 99% represents. Purity describes how much; identity describes what. A study window of days or a few weeks has no slack for resolving that question after the fact.

The shop’s published testing framework reflects this pairing. Research Sciences describes full-spectrum evaluation — purity, identity, heavy metals and endotoxin — rather than a single headline figure, and states that a Certificate of Analysis (CoA) accompanies each compound, covering HPLC purity and identity, with independent testing and final UK verification before release. Where the homepage lists “CoAs Janoshik Analytical Reports”, that is a published statement about documentation sourcing, not a substitute for opening the document itself.

The specific method used to confirm identity is recorded on the batch CoA, and that is where a researcher should look rather than inferring a method from a product listing. Headline claims such as “≥99% Verified Purity” or “UK Research Materials Over 99.1% Purity” are published at the time of writing and should be reconfirmed on the live site and, more importantly, against the CoA supplied with the specific batch in hand. Treat the certificate as the primary record and the marketing figure as an entry point. Materials remain research-use-only and are not for human or veterinary use, nor for diagnostic or therapeutic application.

Building a Short, Stability-Conscious Window Around Two Anchors

In a compressed study design, material is consumed across a defined sequence of timepoints, and the handling between those timepoints is where variability accumulates. Lyophilised material is described in the shop’s guidance as best held at –20°C or below, sealed with desiccant and protected from moisture, heat and light, with repeated freeze–thaw cycles avoided. Once reconstituted for an in-vitro assay, stability is reduced and short-term laboratory storage at 2–8°C is the stated approach. Each of those steps is a chance for the material to change — and change is exactly what a single release-date purity figure cannot describe.

Identity testing therefore belongs at the start of the window as a paired record with purity, and again at a defined checkpoint if the window is long enough to justify it. A practical pattern is to verify identity at baseline against the batch CoA, record the aliquot scheme and diluent volume used for the in-vitro assay, and then schedule a mid-window or end-of-window check where the experimental design is sensitive to drift. Where a lab needs to calculate concentration for assay preparation, the shop’s free reconstitution calculator is explicitly for laboratory research use only and must never be used for human or veterinary dosing.

Sourcing decisions should follow the same logic. A laboratory assembling a short window is buying documentation as much as it is buying material: a coherent paper trail from catalogue entry to CoA to label reference. For UK-based groups, the range of Uk peptides held by Research Sciences is presented with batch-level analytical verification and linked CoAs, alongside preparation tools such as the 10ml Mixing Water and the Storage Container. Catalogue items including Tesamorelin 5mg, TB-500 5mg, Ipamorelin 5mg, CJC-1295 (No DAC) 5mg, GHK-Cu 50mg, MT-1 10mg and BPC-157 10mg are described as research-use-only materials for controlled in-vitro work.

Two handling points deserve emphasis in a short window. First, the FAQs note that peptides contain trace amounts of mannitol as an excipient, used to support lyophilisation and storage behaviour — it is part of the matrix, not a contaminant to be puzzled over. Second, the shop does not supply blended peptides and recommends purchasing individual items and combining them only within a controlled experimental design. Both points reduce ambiguity when a researcher is trying to attribute an unexpected assay result to handling rather than to the material itself. Nothing here is for human or veterinary use, consumption or clinical application.

Documentation Habits for Materials Managers Running Tight Timelines

The label is the fastest identity check available at the bench. Vial labels use a reference format combining SKU code and expiry date — for example BPC10-03/27 — which links to the corresponding CoA. Materials managers should quote that reference whenever contacting the shop about documentation, and should file the CoA alongside the study record rather than in a separate procurement folder that nobody opens during the run.

Two caveats in the shop’s FAQs are worth repeating in any standard operating procedure. Restocked products may carry the same Internal Test Reference (ITR) as earlier stock; an ITR links to associated sample testing reports, but it does not confirm that separate deliveries come from the same production lot or that they have had separate independent testing. Separately, vial cap colours and other packaging may vary, and cap colour is not an indicator of identity, analytical quality or manufacturing origin. Neither caveat undermines the documentation — they simply define what it can and cannot support.

Fulfilment timing also shapes how a short window is planned. The shop states that orders are dispatched the next working day, shipped via Royal Mail Tracked 24, which usually delivers the following working day as a carrier estimate; the homepage’s “24hr UK Delivery” line is a marketing statement and not a guaranteed arrival promise, particularly in peak periods. Tracking is issued after dispatch. Because of the specialist and perishable nature of the goods, returns are not accepted once dispatched, with refunds limited to damage, incorrect supply or quality issues under the Refunds & Returns Policy. Payment is by Pay-By-Bank or Open Banking rather than card, as described on the site.

The final habit is the simplest: pair the two data points in the study record and state the pairing in the protocol. Note the batch CoA reference, the purity figure exactly as the certificate words it, the identity result, the storage conditions from receipt onward, and the date each aliquot entered the assay. Purchasers remain responsible for lawful use, safe handling, storage, disposal and COSHH compliance, and for confirming suitability for their specific research application. Research Sciences materials — including its preparation tools and documentation — are for controlled laboratory and analytical research only, are not medicines, medical devices, injectables, treatments or food supplements, and are not for human or veterinary use.

By Anton Bogdanov

Novosibirsk-born data scientist living in Tbilisi for the wine and Wi-Fi. Anton’s specialties span predictive modeling, Georgian polyphonic singing, and sci-fi book dissections. He 3-D prints chess sets and rides a unicycle to coworking spaces—helmet mandatory.